Description
Founded in 1998, ProQuest Investments was a venture capital firm based in Naples, Florida. The firm preferred to invest in companies operating in the life sciences and healthcare sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
ReVision Optics | 10-Nov-2016 | Later Stage VC | 0000 | Biotechnology | Out of Business | 000 0000 |
00000 000000000000 | 22-Oct-2015 | 0000 | 000.00 | Pharmaceuticals | Generating Revenue/Not Profitable | |
000000 0000000 000 | 23-Jul-2015 | 00000 00000 | 00000 | Diagnostic Equipment | Generating Revenue | 000 000000 |
00000 000000000000 | 23-Jan-2015 | 0000 | 00.000 | Pharmaceuticals | Generating Revenue/Not Profitable | |
000000000 | 15-May-2014 | 0000 00000 | 00000 | Entertainment Software | Out of Business | |
0000000000 | 02-Dec-2013 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | 00000 000000000 00 |
000000 000000 | 30-Oct-2013 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | 00000 000000000 00 |
0000000 0000000000 | 03-Sep-2013 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000 000000000 00 |
ReVision Optics | 29-Jul-2013 | Later Stage VC | 000.00 | Biotechnology | Out of Business | 000 0000 |
Meetin.gs | 25-Jun-2013 | Early Stage VC | 00.000 | Business/Productivity Software | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Cervelo Pharmaceuticals | 01-Jan-2022 | Secondary Transaction - Private | |
000000 00000000000 | 09-Sep-2021 | 0000000 000000 | 000.00 |
0000000 0000000000 | 07-Sep-2021 | 000000000000000000 | |
000000000 | 02-Sep-2021 | 0000000 000000 | 00000 |
000000.00 | 01-Apr-2021 | 000000000 00000000 | |
000000 00000000000 | 01-Apr-2021 | 000000000 00000000 | |
000000 000000 | 28-Mar-2018 | 000000000 00000000 | |
00000000 000000 | 30-Jan-2018 | 000 00 00000000 | |
Eagle Pharmaceuticals | 31-Dec-2017 | Secondary Transaction - Open Market | |
Mersana Therapeutics | 28-Jun-2017 | IPO | 0000 |